CCL4 and diabetes mellitus: A study, comparing the inflammation status in DM with/without nephropathy, demonstrated that plasma levels of proinflammatory monocytes as well as circulatory inflammatory mediators, such as PAI-1, syndecan-1, VEGF, IL-1β, IL-1Ra, and CCL4, increased in nephropathy subjects [41].